Differences in sex development: genes and variants
Explore variant evidence for Differences in sex development across 8 analyzed proteins (AR, SRD5A2, HSD17B3, CYP17A1, AMH and 3 more). Linked ClinVar records include 22 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 3 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Differences in sex development
AR: Androgen receptor
Androgen binding redirects its transcriptional program to control male sexual differentiation, reproductive physiology, muscle and bone biology, and other androgen-responsive processes. Loss-of-function variants cause androgen insensitivity, CAG expansion causes spinal and bulbar muscular atrophy, and persistent signaling drives prostate cancer.
9 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in AR have source records linked to Differences in sex development. Association strength is not clinical gene validity.
SRD5A2: 3-oxo-5-alpha-steroid 4-dehydrogenase 2
It converts testosterone to the more potent androgen dihydrotestosterone in androgen-responsive tissues. Biallelic loss-of-function variants cause 5-alpha-reductase type 2 deficiency, leading to undervirilization of 46,XY individuals and often increased virilization at puberty.
5 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in SRD5A2 have source records linked to Differences in sex development. Association strength is not clinical gene validity.
HSD17B3: 17-beta-hydroxysteroid dehydrogenase type 3
It converts androstenedione to testosterone in the testes, providing a key step in androgen synthesis during male sexual development. Biallelic loss-of-function variants cause 17-beta-hydroxysteroid dehydrogenase 3 deficiency, a 46,XY disorder of sex development.
2 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in HSD17B3 have source records linked to Differences in sex development. Association strength is not clinical gene validity.
CYP17A1: Steroid 17-alpha-hydroxylase/17,20 lyase
Its 17-alpha-hydroxylase and 17,20-lyase activities direct adrenal and gonadal steroid synthesis toward glucocorticoids and sex steroids. Biallelic deficiency causes 17-alpha-hydroxylase/17,20-lyase deficiency with hypertension, hypokalemia, and impaired sexual development.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CYP17A1 have source records linked to Differences in sex development. Association strength is not clinical gene validity.
AMH: Anti-Muellerian hormone
During male fetal development, it drives regression of the Mullerian ducts and therefore prevents formation of female internal reproductive structures. Loss of AMH signaling can cause persistent Mullerian duct syndrome in otherwise virilized 46,XY individuals.
1 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in AMH have source records linked to Differences in sex development. Association strength is not clinical gene validity.
CYP11B1: Cytochrome P450 11B1, mitochondrial
It catalyzes the final step of cortisol synthesis and also contributes to adrenal steroid metabolism. Biallelic loss-of-function variants cause 11-beta-hydroxylase-deficient congenital adrenal hyperplasia, characterized by cortisol deficiency, androgen excess, and frequently hypertension.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in CYP11B1 have source records linked to Differences in sex development. Association strength is not clinical gene validity.
POR: NADPH--cytochrome P450 reductase
It transfers electrons from NADPH to microsomal cytochrome P450 enzymes, making it essential for steroid synthesis and metabolism of many drugs and xenobiotics. Biallelic pathogenic variants cause P450 oxidoreductase deficiency, with disordered steroidogenesis and skeletal abnormalities.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in POR have source records linked to Differences in sex development. Association strength is not clinical gene validity.
CYP19A1: Aromatase
It converts androgens to estrogens and is therefore essential for estrogen biosynthesis in gonads, adipose tissue, placenta, and other sites. Loss-of-function variants cause aromatase deficiency, whereas excessive activity can contribute to estrogen excess; aromatase inhibition is central to treatment of many breast cancers.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CYP19A1 have source records linked to Differences in sex development. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): FGFR1 and HSD3B2.
Where Differences in sex development variants cluster
- AR Interaction with LPXN (positions 552–919): 8 of 9 ClinVar pathogenic / likely pathogenic variants, 2.2× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Differences in sex development
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SRD5A2 A228V | 228 | Pathogenic / likely pathogenic (★★) | |
| SRD5A2 A228T | 228 | Pathogenic / likely pathogenic (★★) | |
| AR L702F | 702 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR R753Q | 753 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR R856L | 856 | NR LBD | Pathogenic / likely pathogenic (★★) |
| SRD5A2 A228G | 228 | Pathogenic / likely pathogenic (★★) | |
| CYP17A1 R96W | 96 | Pathogenic / likely pathogenic (★★) | |
| CYP17A1 R125Q | 125 | Pathogenic / likely pathogenic (★★) | |
| HSD17B3 R80Q | 80 | Pathogenic / likely pathogenic (★★) | |
| CYP11B1 F79I | 79 | Pathogenic / likely pathogenic (★★) | |
| POR A284P | 284 | FAD-binding FR-type | Pathogenic / likely pathogenic (★★) |
| SRD5A2 T120P | 120 | Pathogenic / likely pathogenic (★★) | |
| SRD5A2 E197K | 197 | Pathogenic / likely pathogenic (★★) | |
| AMH G101R | 101 | Pathogenic / likely pathogenic (★★) | |
| AR M1L | 1 | Modulating | Pathogenic / likely pathogenic (★★) |
| AR A871V | 871 | NR LBD | Pathogenic / likely pathogenic (★★) |
| AR A766S | 766 | NR LBD | Pathogenic / likely pathogenic (★) |
| AR I900M | 900 | NR LBD | Pathogenic / likely pathogenic (★) |
| CYP19A1 V370M | 370 | Pathogenic / likely pathogenic (★) | |
| HSD17B3 L212Q | 212 | Pathogenic / likely pathogenic (★) | |
| AR A587D | 587 | Nuclear receptor | Pathogenic / likely pathogenic (★) |
| AR C602F | 602 | Nuclear receptor | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Differences in sex development
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 97 out of 100
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 90 out of 100
- MetaLR: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 90 out of 100
- SIFT: 85 out of 100
- phyloP: 74 out of 100
- SpliceAI: 64 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 32 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Androgen resistance syndrome also has ClinVar records linked to AR variants; they fall mostly in different places as the Differences in sex development variants (85 pathogenic / likely pathogenic).
- Kennedy disease also has ClinVar records linked to AR variants; they fall mostly in different places as the Differences in sex development variants (46 pathogenic / likely pathogenic).
- Male infertility also has ClinVar records linked to AR variants; they fall mostly in different places as the Differences in sex development variants (7 pathogenic / likely pathogenic).
- Partial androgen insensitivity syndrome also has ClinVar records linked to AR variants; they fall mostly in different places as the Differences in sex development variants (7 pathogenic / likely pathogenic).
- Ovarian cancer also has ClinVar records linked to AR variants; they fall mostly in different places as the Differences in sex development variants (4 pathogenic / likely pathogenic).
- 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency also has ClinVar records linked to SRD5A2 variants; they fall mostly in different places as the Differences in sex development variants (43 pathogenic / likely pathogenic).
- Testosterone 17-beta-dehydrogenase deficiency also has ClinVar records linked to HSD17B3 variants; they fall mostly in different places as the Differences in sex development variants (20 pathogenic / likely pathogenic).
- Deficiency of steroid 17-alpha-monooxygenase also has ClinVar records linked to CYP17A1 variants; they fall mostly in different places as the Differences in sex development variants (40 pathogenic / likely pathogenic).
- Adrenal hyperplasia also has ClinVar records linked to CYP17A1 variants; they fall mostly in different places as the Differences in sex development variants (13 pathogenic / likely pathogenic).
- 17-alpha-hydroxylase/17,20-lyase deficiency, combined complete also has ClinVar records linked to CYP17A1 variants; they fall mostly in different places as the Differences in sex development variants (3 pathogenic / likely pathogenic).
- Persistent Mullerian duct syndrome also has ClinVar records linked to AMH variants; they fall mostly in different places as the Differences in sex development variants (4 pathogenic / likely pathogenic).
- Deficiency of steroid 11-beta-monooxygenase also has ClinVar records linked to CYP11B1 variants; they fall mostly in different places as the Differences in sex development variants (33 pathogenic / likely pathogenic).
- Glucocorticoid-remediable aldosteronism also has ClinVar records linked to CYP11B1 variants; they fall mostly in different places as the Differences in sex development variants (20 pathogenic / likely pathogenic).
- Adrenal hyperplasia also has ClinVar records linked to CYP11B1 variants; they fall mostly in different places as the Differences in sex development variants (10 pathogenic / likely pathogenic).
Diseases related to Differences in sex development
- Adrenal hyperplasia, also linked to CYP11B1, CYP17A1 and POR
- Prostate cancer, also linked to AR, CYP17A1 and SRD5A2
- Disorder of sexual differentiation, also linked to AR and HSD17B3
- Androgen resistance syndrome, also linked to AR
- Kennedy disease, also linked to AR
- Ovarian cancer, also linked to AR
- 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, also linked to SRD5A2
- Deficiency of steroid 17-alpha-monooxygenase, also linked to CYP17A1
- Deficiency of steroid 11-beta-monooxygenase, also linked to CYP11B1
- Testosterone 17-beta-dehydrogenase deficiency, also linked to HSD17B3
- Glucocorticoid-remediable aldosteronism, also linked to CYP11B1
- Aromatase deficiency, also linked to CYP19A1
Frequently asked questions
Which genes have records linked to Differences in sex development?
This view contains 8 analyzed proteins: AR, SRD5A2, HSD17B3, CYP17A1, AMH and 3 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 22 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 3 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 31 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center